Happy and proud to have been part of this exciting Trastuxumab Deruxtecan journey and to have provided the HER2m lung cancer patients another amazing treatment option!!!! ascopost.com/news/august-20…

People who received an Omicron booster were more than 18 times less likely to die from Covid and 3 times less likely to be infected compared to unvaccinated people, according to the latest CDC data.

HPV-16/18 DNA vaccine MEDI0457 is safe and efficacious in patients with recurrent/metastatic head and neck squamous cell carcinoma. Efficacy endpoint was not reached but Aggarwal et al showed early and durable clinical responses. bit.ly/3GMGD96 Charu Aggarwal, MD, MPH, FASCO Amaya Gascó MD PhD

Proud of being part of this amazing scientific-driven and patient-oriented company. Thank you Kura Oncology for this great opportunity!!!

Describe approaches to address variances in care for patients with thoracic malignancies at this year's ILC.

Enhorabuena a Secretaría de Gestión Pública - PCM y a Juan Carlos Pasco por organizar una mesa redonda con tan buenos profesionales y amigos. Tuvo que ser excepcional escuchar juntos a Ester Kaufman Mila Gasco y Álvaro V. Ramírez-Alujas 👾 Ojalá haya vídeo! #OpenGovWeek

#UAlbany very excited to celebrate and support #OpenGovWeek! Some great pics of CTG University at Albany and Rockefeller College's Mila Gasco with other #OpenGov experts in Lima, Perú. Thank you Secretaría de Gestión Pública - PCM for hosting and taking good care of Mila! Open Gov Partnership GIGAPP Iberoamérica RedGobernanzaAbierta Red Académica de Gobierno Abierto Internacional L Y

📢Hoy en la Semana del Gobierno Abierto 2023: conferencias de Mila Gasco y Álvaro V. Ramírez-Alujas 👾 sobre iniciativas, retos y experiencias latinoamericanas. 🕗Inscritos: ingreso desde 8:00am 💻Transmisión en vivo: facebook.com/sgp.pcm #OpenGovWeek #GobiernoAbierto #GestiónPública

#OpenGovWeek #GobiernoAbiertoPerú Conferencia de Mila Gasco de CTG UAlbany empezamos el día 2. Secretaría de Gestión Pública - PCM RAGA Perú Juan Carlos Pasco Álvaro V. Ramírez-Alujas 👾 fb.watch/krnpm4IY2S/?mi…

#PhDstudents!!! Are you doing research on #digitalgovernment? You may be interested in joining our ##digitalgoverment specific PhD colloquium in #Hawaii during #HICSS2024: hicssdg.ctg.albany.edu/57/info/HICSS%…. Submissions due by June 30!

Today at the European Hematology Association Annual Congress, we’re presenting the latest data on our potential best-in-class menin inhibitor #ziftomenib for NPM1-mutant #AML. Highlights include 35% complete remission rate and favorable safety profile and tolerability. Read more:

Gracias y enhorabuena a lFundación Ricky Rubio y Dr Santiago Viteri por esta segunda edición del CECOB

Kura Oncology is proud to announce a new trial opening later this year, FIT-001, a clinical trial assessing the safety, tolerability, and preliminary clinical activity in KO-2806, a next generation FTI, in adults with solid tumors. Learn more: kuraoncology.com/clinical-trial…

On #WorldHeadandNeckCancerDay, we raise awareness for head and neck cancer and the unmet need for patients. Access resources from the IFHNOS and learn how to support those living with head and neck cancer: ifhnos.net/whncd/Index/

Día Mundial Cáncer Campaña Ejercicio youtu.be/CwtjhkfO6jQ?si… a través de YouTube

More insights from the plenary session “AI at the Interface: Accelerating Evidence Generation, Advancing Disparities Research, and Improving Trial Design” at the #AACR24 Annual Meeting at the link here: aacrmeetingnews.org/news/plenary-s…

Continuing with a satellite symposium at #ISLB24 by @FoundaATCG discussing on they new pipeline and concepts as Tumor Fraction data. Elsa Anagnostou International Society of Liquid Biopsy

Amazing #ISLB24 congress in summary: 303 participants, 24 countries 🌎 100 abstracts 📝 50 speakers 👨‍🏫👩‍🏫 26 travel awards ✈️ 3 ISLB awards🥇 32 sponsors 5 satellite symposium ✏️ THAKS ALL OF YOU “THE” INTERNATIONAL LIQUID BIOPSY SOCIETY IS GROWING EVERY YEAR ! International Society of Liquid Biopsy

#ASCO25 1st practice changing presentation, which has already been our practice since the initial readout for our patients with #BRAFV600E mutant colorectal cancer. More options for our patients.👏🏽 OncoAlert